[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Author:

Hofman Michael S,Emmett Louise,Sandhu Shahneen,Iravani Amir,Joshua Anthony M,Goh Jeffrey C,Pattison David A,Tan Thean Hsiang,Kirkwood Ian D,Ng Siobhan,Francis Roslyn J,Gedye Craig,Rutherford Natalie K,Weickhardt Andrew,Scott Andrew M,Lee Sze-Ting,Kwan Edmond M,Azad Arun A,Ramdave Shakher,Redfern Andrew D,Macdonald William,Guminski Alex,Hsiao Edward,Chua Wei,Lin Peter,Zhang Alison Y,McJannett Margaret M,Stockler Martin R,Violet John A,Williams Scott G,Martin Andrew J,Davis Ian D,Azad Arun A,Chua Wei,Davis Ian D,Dhiantravan Nattakorn,Emmett Louise,Ford Kate,Hofman Michael S,Francis Roslyn J,Gedye Craig,Goh Jeffrey C,Guminski Alex,Hsiao Edward,Iravani Amir,Joshua Anthony M,Kirkwood Ian D,Langford Ailsa,Lawrence Nicola,Lee Sze-Ting,Lin Peter,Martin Andrew J,McDonald William,McJannett Margaret M,Ng Siobhan,Pattison David A,Ramdave Shakher,Rana Nisha,Redfern Andrew D,Rutherford Natalie K,Sandhu Shahneen,Scott Andrew M,Stockler Martin R,Subramaniam Shalini,Tan Thean Hsiang,Violet John A,Weickhardt Andrew,Williams Scott G,Yip Sonia,Zhang Alison Y

Funder

Endocyte

Movember Foundation

Prostate Cancer Foundation of Australia

Publisher

Elsevier BV

Subject

General Medicine

Cited by 652 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. 177Lu-PSMA-617 for metastatic prostate cancer in India;The Lancet Regional Health - Southeast Asia;2024-11

2. Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer;Clinical and Translational Oncology;2024-09-12

3. Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-03

4. Guía rápida de procedimiento de la PET/TC con PSMA;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

5. PSMA PET/CT quick procedure guide;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3